On September 25-29, 2016, the 28th Congress of the European Society of Pathology will take place in Cologne, Germany. For the first time the congress will be arranged as a joined venture with the XXXI International Congress of the International Academy of Pathology.
We're looking forward to meet you there and present QIAGEN Clinical Insights and our solutions for hereditary diseases.
Would you like to know more the GeneReader NGS System and our Sample to Insight solution? You're welcome to join our symposium:
Time and date: September 26 from 1:00 p.m. to 2:30 p.m.
Location: Congress Hall 3
Program:
The new NGS solution to investigate cancer - QIAGEN’s sample to insight approach
Salim Essakali, QIAGEN, Germany
The GeneReader NGS System: experience of a complete NGS workflow solution
Margarethe Odenthal, PD. Dr., Pathology Institute, Universitätsklinikum Cologne, Germany
Qiagen Clinical Insight – Clinical interpretation and reporting of complex NGS data made simple
Ian Cook, Advanced Genomics Clinical Sales Specialist, QIAGEN
Learn more about our hereditary disease solution
Get more details about ESP
The EU funded PATHSEEK consortium, made up of four partners, is working towards a concept of sequencing whole pathogen genomes, e.g. HIV and Mycobacterium tuberculosis, directly from clinical samples. By enriching pathogen genomes directly from clinical samples, quality of sequence is improved so that it can be used to identify outbreaks and resistance. The method can be carried out in a single tube allowing the process to be automated and the sensitivity of the method identifies resistance occurring even at low level.
Our role in PATHSEEK has been to develop the project's bioinformatics software - a flexible and user-friendly software platform for the analysis of sequencing data by clinical researchers*. We've developed the software to be accessible to users having varying degrees of expertise within bioinformatics - such as clinicians, clinical scientists, and bioinformaticians.
Recently, the coordinator of the project, Professor Judith Breuer, presented results from the research and the progress of the project aiming to develop a next-generation sequencing platform for use in diagnostic microbiology.
Read the full publication: An exciting and ambitious path to progress
